AKT1 and Familial prostate cancer: Collectively, SsnB inhibits tumour growth and induces apoptosis in prostate cancer via the suppression of the ROS‐mediated PI3K/AKT pathway and may be a new alternative to adjuvant therapy for prostate cancer.